The use of sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier in gynecologic malignancies: A retrospective review of outcomes

Annals of Surgical Oncology

Volumn 16, Issue 2, 2009, Pages 499-505

  Tan, Annie ^a   Argenta, Peter ^a   Ramirez, Rose ^a   Bliss, Robin ^a   Geller, Melissa ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARBOXYMETHYLCELLULOSE; DOXORUBICIN; HYALURONIC ACID; PACLITAXEL; PLATINUM; TAXANE DERIVATIVE;

ABSCESS; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; DEEP VEIN THROMBOSIS; FEMALE; FEVER; HUMAN; ILEUS; INTESTINE OBSTRUCTION; INTRAOPERATIVE PERIOD; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVARY CANCER; PERITONEUM CANCER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY; TUMOR GROWTH; UTERINE TUBE CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; HYALURONIC ACID; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 59449086712     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0235-1     Document Type: Article

References (28)

1. RE Bristow A Santillan TP Diaz-Montes 2007 Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate- carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis Gynecol Oncol 104 739 46
2. M Al-Sunaidi T Tulandi 2006 Adhesion-related bowel obstruction after hysterectomy for benign conditions Obstet Gynecol 108 1162 6
3. S Al-Took R Platt T Tulandi 1999 Adhesion-related small-bowel obstruction after gynecologic operations Am J Obstet Gynecol 180 313 5
4. MC Parker H Ellis BJ Moran 2001 Postoperative adhesions: ten-year follow-up of 12, 584 patients undergoing lower abdominal surgery Dis Colon Rectum 44 822 9
5. JM Becker MT Dayton VW Fazio 1996 Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study J Am Coll Surg 183 297 306
6. MP Diamond 1996 Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group Fertil Steril 66 904 10
7. S Tsuji K Takahashi H Yomo 2005 Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma Eur J Obstet Gynecol Reprod Biol 123 244 8
8. RE Bristow FJ Montz 2005 Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier Gynecol Oncol 99 301 8
9. BP Toole TN Wight MI Tammi 2002 Hyaluronan-cell interactions in cancer and vascular disease J Biol Chem 277 4593 6
10. M Gotte GW Yip 2006 Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective Cancer Res 66 10233 7
11. PM Carpenter AV Dao 2003 The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells Anticancer Res 23 3985 90
12. C Laurich MA Wheeler J Iida 2004 Hyaluronan mediates adhesion of metastatic colon carcinoma cells J Surg Res 122 70 4
13. B Tan JH Wang QD Wu 2001 Sodium hyaluronate enhances colorectal tumour cell metastatic potential in vitro and in vivo Br J Surg 88 246 50
14. SC Hubbard JW Burns 2002 Effects of a hyaluronan-based membrane (Seprafilm) on intraperitoneally disseminated human colon cancer cell growth in a nude mouse model Dis Colon Rectum 45 334 41
15. S Pucciarelli L Codello A Rosato 2003 Effect of antiadhesive agents on peritoneal carcinomatosis in an experimental model Br J Surg 90 66 71
16. G Makrydimas N Zagorianakou P Zagorianakou 2003 CD44 family and gynaecological cancer In Vivo 17 633 40
17. Z Rudzki S Jothy 1997 CD44 and the adhesion of neoplastic cells Mol Pathol 50 57 71
18. I Oikonomakis SD Wexner P Gervaz 2002 Seprafilm: a retrospective preliminary evaluation of the impact on short-term oncologic outcome in colorectal cancer Dis Colon Rectum 45 1376 80
19. M Kusunoki H Ikeuchi H Yanagi 2005 Bioresorbable hyaluronate- carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial Surg Today 35 940 5
20. DE Beck Z Cohen JW Fleshman 2003 A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine Dis Colon Rectum 46 1310 9
21. MR Salum DT Lam SD Wexner 2001 Does limited placement of bioresorbable membrane of modified sodium hyaluronate and carboxymethylcellulose (Seprafilm) have possible short-term beneficial impact? Dis Colon Rectum 44 706 12
22. CL Tang F Seow-Choen S Fook-Chong 2003 Bioresorbable adhesion barrier facilitates early closure of the defunctioning ileostomy after rectal excision: a prospective, randomized trial Dis Colon Rectum 46 1200 7
23. P Rooney M Wang P Kumar 1993 Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells J Cell Sci 105 Pt 1 213 8
24. K Ropponen M Tammi J Parkkinen 1998 Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer Cancer Res 58 342 7
25. P Rooney S Kumar J Ponting 1995 The role of hyaluronan in tumour neovascularization Int J Cancer 60 632 6
26. RA Underwood JS Wu MP Wright 1999 Sodium hyaluronate caroxymethycellulose-based bioresorbable membrane (Seprafilm)-does it affect tumor implantation at abdominal wound sites? Dis Colon Rectum 42 614 9
27. T Sasaki H Shimura T Tanaka 2004 Protection of trocar sites from gallbladder cancer implantation by sodium hayluronate shill carboxymethycellulose-based bioresorbable membrane (Seprafilm) in a murine model Surg Endosc 18 246 51
28. NM Spirtos SM Eisenkop JB Schlaerth 2000 Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer Am J Obstet Gynecol 182 1321 7